The SARS-CoV-2 IgM assay is a chemiluminescent microparticle immunoassay (CMIA) used for the qualitative detection of IgM antibodies to SARS-CoV-2 in human serum and plasma on the Alinity i and ARCHITECT i Systems.
- Used as an aid in the diagnosis of SARS-CoV-2 infection in conjunction with clinical presentation and other laboratory tests
- The positive agreement between the ARCHITECT i2000sr and the Alinity i was 100.00% and the negative agreement was 99.97%.
The SARS-CoV-2 IgM Kit for Detecting SARS-CoV-2 is manufactured and approved for use by the Therapeutic Goods Administration (TGA) .
Buy the SARS-CoV-2 IgM Kit for Detecting SARS-CoV-2 for Your WorkPlace
If your company or organisation is interested in rapid testing solutions, contact us today for help procuring the SARS-CoV-2 IgM Kit for Detecting SARS-CoV-2 for detecting SARS-CoV-2 or other rapid tests authorised by the Therapeutic Goods Administration (TGA) .
If you’re interested in rapid testing solutions, contact us today for a quote. You can also place an order for the SARS-CoV-2 IgM Kit for Detecting SARS-CoV-2 or other rapid tests approved by the TGA.
Our team at Rapid Tests Australia can also assist with implementing a rapid testing program to protect your workplace from the risks of COVID-19.
